Fauchier, Laurent http://orcid.org/0000-0002-9267-1658
Bisson, Arnaud
Bodin, Alexandre
Herbert, Julien
Angoulvant, Denis
Danchin, Nicolas
Cottin, Yves
Article History
Received: 7 November 2020
Accepted: 9 January 2021
First Online: 28 January 2021
Compliance with ethical standards
:
: LF: consultant or speaker activities for Bayer, BMS/Pfizer, Boehringer Ingelheim, Medtronic, and Novartis. BP: personal fees from Abbott, Biotronik, Boston Scientific and Microport. NC: consultant activities for Medtronic and Boston Scientific. ND: personal fees and nonfinancial support from Amgen, AstraZeneca, BMS, Bayer, Pfizer, Boehringer Ingelheim, Intercept, MSD, Novo Nordisk, Sanofi, Servier, and UCB, outside the submitted work. YC: Consultant or speaker for Bayer, BMS/Pfizer, Boehringer Ingelheim, Novartis, Sanofi and Servier. All other authors declare no competing interests.
: The study was conducted retrospectively and, as patients were not involved in its conduct, there was no impact on their care. Ethical approval was not required, as all data were anonymized. The French Data Protection Authority granted access to the PMSI data. Procedures for data collection and management were approved by the Commission Nationale de l'Informatique et des Libertés, the independent National Ethical Committee protecting human rights in France, which ensures that all information is kept confidential and anonymous, in compliance with the Declaration of Helsinki (authorization number 1897139).
: Not applicable.
: Not applicable.
: The data and study materials will not be made available to other researchers for purposes of reproducing the results or replicating the procedure. Because this study used data from human subjects, the data and everything pertaining to the data are governed by the French Health Agencies and cannot be made available to other researchers.